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A B S T R A C T
The purpose of our study was to investigate the association between perioperative cerebral microembolization, ex-
pressed as high-intensity transient signals (HITS) and postoperative dynamics of the neuromarker S100b in patients op-
erated using cardiopulmonary bypass, and to assess their impact upon the neurocognitive function in the early postoper-
ative stage. The study involved 62 consecutive male patients aged 60 or above, alls scheduled for elective aortocoronary
bypass. The patients were recruited from two groups with respect to the use of CPB: on-pump group (CPB+, N=30) and
off-pump group (CPB–, N=32). In all patients we performed intraoperative monitoring of cerebral haemodynamics us-
ing transcranial Doppler, with the goal of quantifying perioperative cerebral microembolization. The serum levels of the
neuromarker S100b were measured immediately after surgery, and then 12, 24 and 48 hours after the surgery1. Neuro-
cognitive status was assessed before and after the surgery and in three cognitive domains. Results of the study have
shown that with respect to the short-term postoperative neurocognitive outcome there is no significant difference between
the on-pump and off-pump surgical technique of coronary revascularization1. Perioperative cerebral microembolization
was significantly more pronounced in the on-pump group yet it did not affect early postoperative neurocognitive function,
while the increase in the neuromarker S100b serum level 48 hours after surgery may have prognostic value as a predictor
of postoperative neurocognitive dysfunction.
Key words: cerebral microembolization, high-intensity transients signals (HITS), neuromarker S100b, cardiopul-
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Introduction
Cardiac surgery using cardiopulmonary bypass (on-
-pump surgery) is the main cause of intraoperative mi-
croemboli and brain hypoperfusion. Although in the last
two decades cardiac surgery has seen significant im-
provement, a substantial proportion of patients still ex-
periences temporary or permanent postoperative neuro-
logical deficit1. Perioperative stroke is found in 23%
adult patients who underwent cardiac surgery, while sig-
nificant cognitive dysfunction appears in 4060% of pa-
tients during the first postoperative week. A long-term
cognitive dysfunction, lasting months and years, has
been registered in 2540% of patients and it has a signifi-
cant negative impact upon their quality of life1. The clini-
cal significance of diagnosed emboli in brain circulation
is not entirely clear. While some patients remain asymp-
tomatic, many studies have revealed association between
cerebral microembolism and clinical symptoms1,2. The
negative effect of microembolism upon short-term and
long-term neurocognitive outcome is emphasized espe-
cially in the context of early and delayed post-operative
cognitive dysfunction (POCD)1,3. Microembolic signals,
also known as high-intensity transient signals (HITS),
are detected using transcranial Doppler (TCD) as unidi-
rectional signals of high intensity, having short duration
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and appearing at irregular intervals4. They sound like
»whistles«1. In cardiac surgery microemboli may come
from air bubbles or solid particles (fat, atheromatous ma-
terial, platelet conglomerates). Several studies examined
which procedures during surgery increased the number
of emboli: more than 60% of emboli were registered dur-
ing heart or aorta manipulation, while more than 10%
were recorded in the two minutes following the removal
of clamps3,4,6. Yet over 1/3 of embolic signals were not as-
sociated with any specific period or surgical procedure1,5.
Also, it was noted that patients with postoperative neu-
rological deficit had more than twice as many embolic
signals than patients who had no registered neurological
deficit2,3. More recently, numerous studies have explored
the possibility of using protein S100b as a marker of
brain damage following cardiac surgery using cardio-
pulmonary bypass7. So far conclusions have been ambig-
uous. Under normal conditions, protein S100b is not
found in circulation3,4,6. It is released from glia cells in re-
sponse to stress or to the use of extracorporeal circula-
tion (cardiopulmonary bypass) as well as after a neuro-
logical injury4. The biological halftime of S100b is two
hours. As the t½ of S100b is short, its serum concentra-
tion may only be maintained if continually released3.
Thus the presence of S100b in peripheral blood for more
than 24 hours probably indicates brain damage2. Al-
though S100b is believed to be highly brain-specific, the
main problem lies in the fact that its concentration is in-
creased by the release from extra-cerebral tissues, in the
first place traumatised fat tissue, skin and bone mar-
row4,5. It is precisely the extra(-)cerebral S100b that hin-
ders elucidation of the increase of its serum concentra-
tion following cardiac surgery8. Thus its release in the
early stage following cardiac surgery cannot be used to
conclude with any certainty about potential neurological
damage following cardiac surgery9. Late increase of S100b
serum concentration, after 24 to 48 hours, is considered
as a more reliable indicator of perioperative cerebral
complications such as stroke, late awakening from an-
aesthesia or the appearance of confused and disoriented
behaviour2,8. The goal of this article is to investigate
whether there is a significant postoperative increase of
the serum level of the neuromarker S100b. Furthermore,
association between postoperative neurocognitive func-
tion and the dynamics of the neuromarker S100b is
analyzed. The second important goal of this study is to
quantify perioperative cerebral microembolization by re-
gistering high-intensity transient signals (HITS) using
transcranial Doppler ultrasound (TCD) and establish if




We conducted a prospective study that involved 62
male coronary patients aged 60 or more years, scheduled
for elective aortocoronary bypass procedure. Participants
were recruited from two groups with respect to the use of
cardiopulmonary bypass (CPB): (1) on-pump group (with
the use of CPB, N=30, consecutive) and (2) off-pump
group (no use of CPB, N=32, consecutive). Clinical ex-
clusion criteria for this study were: occlusion or haemo-
dynamically significant stenosis of carotid arteries (>70%),
acute ischemic damage of myocardium, unstable angina,
ejection fraction <30%, persistent atrial fibrillation, se-
vere liver or kidney disease, malignancies, severe dia-
betic neuropathy, mental illness, alcohol and drug addic-
tion.
Methods
Intraoperative monitoring of cerebral haemodynamics
using transcranial Doppler was performed in all patients
for the purpose of quantifying perioperative cerebral
microembolization. Serum levels of the neuromarker
S100b were measured before, immediately after, and 12,
24 and 48 hours after the surgery. The patient’s neuro-
cognitive status was assessed before and after surgery in
three cognitive domains.
S100b analytical method
S100b analytical method is biochemical assessment of
the marker S100b in peripheral blood samples9. Sam-
pling was conducted in accordance to the set schedule, at
five time points: one day before the surgery (T1), at ad-
mission in intensive care unit (T2), 12 hours after the
surgery (T3), 24 hours after the surgery (T4) and 48 after
the surgery (T5). The serum concentration of protein
S100b was measured using immunoluminometric labora-
tory set that comprises monoclonal antibody for diagnos-
ing S100b in dimeric isoforms and enables analytic sensi-
tivity of 0.02 mg/L9. Concentration exceeding 0.12 mg/L
is considered pathologically high2.
Intraoperative monitoring using transcranial
Doppler
To detect embolic signals, we used a 2-MHz pulse
TCD system for continuous intraoperative measurement
of blood flow in middle cerebral artery (arteria cerebri
media, ACM) simultaneously at two depths between 50
and 55 mm10. The recording method assumes that ultra-
sound acts upon both middle cerebral arteries through
temporal windows following fixation (with a rubber fra-
me) of both probes transtemporally above right and left
zygomatic arches.
Neurological and neurocognitive assessment
A neurologist conducted the initial examination 24
48 h following the hospital admission, 48 hours after the
surgery, 5th day after the surgery and one day before the
discharge. The first clinical psychological examination
took place 2448 hours following admission and then
postoperatively 5th–7th day after the surgery. The follow-
ing tests were used in the patient assessment: CPM (col-
oured progressive matrices) Raven – non-verbal test of
general intelligence and WB II (Wechler-Bellevue Scale –
second revision) intelligence test – four subtests were
used for specific cognitive abilities from WB-II: Verbal
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(mechanical memory of numerical sequences and mathe-
matical-logical thought) and Non-verbal (perceptual speed
and oculomotor coordination and ability to organize ab-
stract material)10. Test of verbal fluency (TVF) were also
used.
Operative procedure and postoperative course
All patients received standard general anaesthesia
and in all cases total median sternotomy was performed.
Because systemic anticoagulation is a precondition of
extracorporeal circulation, just before their connection
to CPB, the patients received 3 mg/kg of their body mass
of heparin to achieve activated coagulation time of 480
seconds. Following their separation from CPB, heparin
was neutralized with protamine sulphate. In the off-pump
group, patients received 1 mg/kg of body mass of heparin
and the myocardial stabilization was achieved using vac-
uum stabilizer. Following the completion of all anastomo-
ses, heparin was neutralized using protamine sulphate2.
Details of the surgical procedure as well as cardiac sur-
gery procedures that were performed using standardized
methods and techniques are described in literature2,3.
Statistical analysis
Data were analyzed using 2-test and Fisher’s exact
test for the comparison of categorical variable distribu-
tions as well as Student t-test and Mann-Whitney U-test
for the comparison of quantitative variable distributions.
Correlation analysis and multivariate regression analysis
were conducted to establish association between quanti-
tative variables. To determine if there is a difference in
the dynamics of individual quantitative variables be-
tween groups, we used repeated-measures analysis of
variance, Friedman ANOVA.
Results
The age distribution did not significantly differ be-
tween study groups (CPB+ versus CPB–, 66.7±5.9 vs.
66.6±6.2 years of age; t=–00906; p=0.928). As the age
distribution in each of the two groups was almost en-
tirely comparable, it was not necessary to conduct the
standardization of neurocognitive tests with respect to
age, also because when assessing the effect on neurocog-
nitive functions patients were their own controls. In both
groups prior to surgery (T1) S100b values were very low
with the median value of 0 mg/L. Immediately after the
surgery (T2) these values increased significantly to reach
1.2455 (CPB+) and 0.334 mg/L (CPB–) (p<0.001 for
both groups). Twelve hours after the surgery S100b con-
centrations fell to 0.1035 and 0.0525 respectively (p<
0.001 for both groups). Twenty-four hours after the sur-
gery the values of S100b in CPB+ group decreased to
0.058 mg/L (t=0.89; p=0.3766), while in CPB– remained
at the level recorded earlier (median value 0.063 mg/L,
t=–0.36; p=0.7197). Forty-eight hours after the surgery
in CPB+ group the value stayed at 0.0505 mg/L (t=0.13;
p=0.9008), while in group CPB– they exhibited a signifi-
cant decrease (median 0 mg/L; t=2.49; p=0.0185). Pe-
rioperative cerebral microembolization was assessed by
measuring high-intensity transient signals (HITS)11. As
expected, the CPB+ group had significantly higher val-
ues (X±SD, 771±221.5 HITS) than CPB– group (X±SD,
135±109.4 HITS; z=–6.7049; p<0.001). When comparing
two study groups, it was noticed that there was a statisti-
cally significant difference in the value of the measured
neuromarker S100b at T2, that is just after admission in
intensive care unit (z=–5.9161; p<0.001) with CPB+
showing a higher number of HITS and a higher level of
S100b (median CPB+ 1.2455 mg/L vs. CPB– 0.334 mg/L).
At the same time, CPB+ group also had a higher increase
of S100b (X±SD, 1.3249±0.6781 mg/L) when compared to
the initial (preoperative) value, and the equivalent in-
crease in CPB– group (X±SD, 0.4006± 0.3117 mg/L; z=
–5.9019, p<0.001). When comparing the entire dynamics
of the neuromarker S100b in two study groups, despite of
the differences described above, the difference in the
time dynamics failed to reach statistical significance (c2=
7.600; df=4; p=0.1074; Friedman ANOVA; Figure 1). We
found no statistically significant difference between groups
for any of the parameters used to measure neurocogni-
tive function initially (preoperatively) (CPM, t=0.7549,
p=0.453; WBP, t=0.4749, p=0.637; WBR, t=1.1841, p=
0.241; WBK, t=1.5569, p=0.125; WBS, t=–0.6548, p=
0.515; TVF, t=0.7153, p=0,477). Furthermore, no statis-
tically significant difference between groups was found
for any of the neurocognitive function parameters at
postoperative measurements (CPM, t=0.8760, p=0.385;
WBP, t=0.8598, p=0.394; WBR, t=–0.2307, p=0.818;
WBK, t=0.8386, p=0.405; WBS, t=–0.7419, p=0.461;
TVF, t=–0.2714, p=0.787). Also no statistically signifi-
cant differences were found between groups for most dif-
ferences between initial and postoperative measurement
of neurocognitive function parameters (CPM, z=0.3804,
p=0.704; WBP, z=1.3541, p=0.176; WBK, t=–0.8806,
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Fig. 1. Time dynamics of the neuromarker S100b values in two
study groups, depending on the use of cardiopulmonary bypass
(CPB). The graph shows arithmetic mean ±95% confidence inter-
val of the arithmetic mean, T1: one day before the surgery; T2: at
admission in intensive care unit; T3: 12 hours after the surgery;
T4: 24 hours after the surgery and T5: 48 after the surgery.
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p=0.382; WBS, t=–0.1287, p=0.898; TVF, t=–1.3338,
p=0.188). The only exception was WBR for which statis-
tically significant difference was found (t=–2.2852, p=
0.026) characterized by an increase of the values in
CPB+ after surgery (X±SD; 0.4±1.0) and a decrease of
the values in CPB– (X±SD; –0.3±1.3). Correlation analy-
sis of association between the number of HITS and the
level of the neuromarker S100b found a statistically sig-
nificant difference between the level of S100b immedi-
ately after surgery as well as 48 hours after the surgery
and the number of HITS (Spearman R=0.708, p<0.0001;
Spearman R=0.269, p= 0.0359; consequently) when both
groups were analysed together (Figure 2 and 3). When
the same association was studied for the group CPB– no
statistically significant association of the number of
HITS with the level of S100b was found for any of the
time points (p>0.25 for all time points). Only in the
CPB+ group we found statistically significant correla-
tion between the number of HITS and the level of S100b
at all-time points (p<0.05 for all time points). When ana-
lysing the association between postoperative cognitive function and time dynamics of the level of the neuro-
marker S100b we found a statistically significant associa-
tion only for the postoperative value of nonverbal test of
general intelligence (CPM) and the postoperative level of
S100b 48 hours after the surgery (Spear- man R=–0.337;
p=0.0098) as well as the level of increase of S100b in
comparison to the preoperative measurement (Spearman
R=–0.366; p=0.0048; Figure 4). At the same time, no
statistically significant association between the number
of HITS and any of the parameters used to assess postop-
eratively neurocognitive function (p>0.05 for all). Multi-
variate regression analysis (forward stepwise) used post-
operative values of neurocognitive parameters and their
change with respect to initial measurement as dependent
variables, while age, levels of neuromarker S100b, its dy-
namics and the number of perioperative HITS were used
independent variables11,12. The analysis showed a statis-
tically significant association for a large number of neu-
rocognitive parameters with independent variables. Thus
the postoperative value CPM is statistically significantly
associated with the increase of S100b at T3 and T5 time
points (r=0.4203; p=0.0058). A change in CPM is statis-
tically significantly associated with an increase in S100b
at T2 and T3 tie points (r=0.3431; p=0.0300). Postopera-
tive value of WBP is statistically significantly associated
with age and the increase of S100b at T5 (r=0.4284;
p=0.0046) while the change in WBP has not shown such
association. Postoperative value of WBR is statistically
significantly associated with the same two variables (age
and the increase of S100b at T5; r=0.3440; p=0.0355).
Yet its change was not statistically significantly associ-
ated with independent variables. Postoperative value of
WBK was statistically significantly associated with age
r=0.4608; p= 0.0002) and its change with increase of
S100b at T5 (r=0.2875; p=0.0286). Postoperative value
of WBS was statistically significantly associated with age
and the increase of S100b at T4 (r=0.4736; p=0.0012).
Its change was not statistically significantly associated
with independent variables. Postoperative value of TVF
and its change were not statistically significantly associ-
ated with independent variables.
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Fig. 2. Diagram of dispersion function for the association be-
tween the number of high-intensity transients signals (HITS)
and the level of S100b at admission in intensive care after the
surgery (N=62).
Fig. 3. Diagram of dispersion function for the association be-
tween the number of high-intensity transients signals (HITS)
and the level of S100b 48 hours after the surgery (N=61).
Fig. 4. Diagram of the dispersion function for the association be-
tween the level of S100b 48 hours after surgery and the postoper-
ative values in coloured progressive matrices (CPM) test (N=61).
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Discussion
Although literature2,6,7,11,12 indicates that cognitive
dysfunction appears in 479% of cardiac surgery cases,
steps necessary for diagnosing this condition are rarely
undertaken. The wide range of the published rate of
postoperative cognitive dysfunction (POCD) is probably
the consequence of several factors: differences in surgical
procedures used to perform coronary artery bypass graft
(CABG) surgery; differences in methods used to assess
neurocognitive dysfunction, varying duration of the pa-
tient follow-up, as well as lack of studies with control
groups2,13,14. The gold standard for the confirmation of
cognitive dysfunction is neuropsychological testing,
which is complex and difficult to carry out15. Recently,
protein S100b has been suggested as a simple method for
diagnosing cognitive dysfunction following cardiac sur-
gery15. This protein is believed to be the serummarker of
brain damage in patients that underwent cardiac sur-
gery2,3,16. This protein belongs to the large group of S100
proteins and it is one of the two isoforms of this protein,
believed to be brain-specific2,4,16. Recently, many studies
have raised the question if S100b could be used as a
marker of cognitive dysfunction following cardiac sur-
gery. So far conclusions have been far from unambi-
guous17. One of the main reasons is the fact that S100b is
present at high concentrations in mediastinal blood that
is returned to the patient using cardiotomy suction or
autotransfusion, which in turn thwarts accurate mea-
surements of S100b levels in the early postoperative
stage18. To the present day only one published study has
taken into account this type of »contamination«2,19. An-
derson et al. have shown that blood that leaks into
mediastinum during surgery contains high levels of
S100b2,20. When this blood is returned into circulation di-
rectly using cardiotomy suction or later during postoper-
ative care using autotransfusion, it affects the level of
S100b in the systemic circulation21. This S100b is not of
cerebral but extracerebral origin and it probably comes
from S100b-containinig tissues, probably fat tissue, skin
and bone marrow. The reabsorption of S100b from dam-
aged fat tissue undoubtedly contributes to the levels of
S100b measured in the serum. A study by Jönsson et al.
has shown that protein S100b has complex dynamics
with the pattern of early and late release21. The study
has also demonstrated association between the serum
level of protein S100b in the hours immediately following
the surgery and the neurocognitive outcome21,22. Yet it
did not offer a definitive conclusion concerning the time
point that would provide most information for the pre-
diction of POCD21. Therefore the authors emphasize the
importance of multiple measurements of the postopera-
tive serum levels of S100b and argue that a single mea-
surement of S100b during postoperative follow-up is not
useful for clinical prediction of neurocognitive outcome,
because it is not sufficiently sensitive2,3,20–23. Our study
has found an increase of the serum S100b levels in the
early stage immediately after the surgery with a statisti-
cally significant difference between two groups. Increase
in the concentration of S100b was much more pronoun-
ced in the on-pump group. In the late stage, 48 hours af-
ter surgery, a small increase of the serum S100b level was
found in the on-pump group only. Although the differ-
ence between two groups is not statistically significant, it
is still evident. So if we take into account the result of
correlation analysis that found statistically significant
association between the S100b serum levels 48 hours af-
ter surgery and one of the postoperative cognitive func-
tion parameters, then we reach one of the most impor-
tant conclusions of this study. This conclusion is that the
late increase of serum S100b found in the on-pump group
may have a prognostic value in patients with no clinical
signs of brain damage. Cardiovascular surgery with the
use of cardiopulmonary bypass machine (on-pump) is
probably the main cause of intraoperative microemboli
and cerebral hypoperfusion. A study by Bowles et al. has
shown that stroke and neurocognitive dysfunction are
correlated with cerebral microembolism generated by
cardiopulmonary bypass machine23. That study was ba-
sed on a retrospective analysis of the results collected
from 137 patients who underwent elective CABG. While
70 patients underwent traditional CABG, 67 underwent
OPCABG (off-pump CABG)23,24. Significantly lower num-
ber of cerebral microemboli and better clinical results
(fewer strokes and deaths) were found in the off-pump
group. These results speak in favour of the off-pump sur-
gical strategy as a both sustainable and potentially harm-
less alternative to the traditional CABG2,6,11,12,24. Results
of our study demonstrate that perioperative cerebral
microembolization is statistically significantly more fre-
quent in the on-pump group in comparison with the
off-pump group (z=–6.7049; p<0.001). Yet we found no
statistically significant association between early postop-
erative neurocognitive function and the number of mi-
croemboli (HITS) (p>0.05 for all). It is surprising that in
spite of the strong association between the number of
microemboli and S100b level in the on-pump group,
which was found in all postoperative measurements,
there was no statistically significant association between
the number of microemboli and any of the parameters
used for the postoperative assessment of neurocognitive
function25. This finding may be explained in many ways,
and possibly the most acceptable explanation is that in
these cases cerebral microemboli were asymptomatic and
did not have the expected clinical significance in the
early postoperative stage3,11,25. Yet delayed cognitive dys-
function may still develop in these patients, caused by
the phenomenon of the cumulative effect of embolism6,25.
It is important to stress that emboli rarely cause immedi-
ate neurological symptoms12,23,26. Rather, it seems that
the cumulative effect of cerebral microembolism with a
resulting long-term cognitive dysfunction is more clini-
cally significant2,6,7,12,21,27. One of the issues in cardiac
surgery that causes the most heated debates is the ques-
tion whether the surgical technique of direct revascu-
larization of myocardium (off-pump) has advantage over
the conventional procedure that uses cardiopulmonary
bypass (on-pump) with regard to neurocognitive surgical
outcome10,11,15,21. Although more procedures are perfor-
med on a beating heart, so far research has failed to pro-
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duce definite proof of the superiority of the off-pump
over the on-pump surgical procedure12,19,28. This study
shows that with respect to the short-term neurocognitive
outcome there is no significant difference between on-
-pump and off-pump surgical technique of coronary re-
vascularization. It is obvious that the use of cardiopul-
monary bypass is not the only factor contributing to the
postoperative cognitive dysfunction; the latter owes its
emergence to a multifactorial mechanism. Results of our
study match the results of the latest multicentric study,
named ROOBY (Randomized On/Off Bypass trial) by
Shroyer and al, published in 200925. They go against all
the other published studies with respect to the advantage
of »on/off« approach25. This prospective multicentric stu-
dy lasted for six years (2002–2008) and included as many
as 2203 patients, almost exclusively men, who were
scheduled for either emergency or elective CABG and
randomized to on-pump or off-pump procedure2,25.
ROOBY study did not find significant differences be-
tween the groups with respect to the neuropsychological
outcome, and its results did not show weakening of cog-
nition within a year of the surgery in either of the
groups25. Instead, it found a consistent trend towards
better outcome in patients who had had conventional
on-pump CABG procedure, including a better complex
outcome indicator after one year and better rate of by-
pass patency after one year25,26. This is an important out-
come as numerous previous studies indicated that
on-pump surgical technique results in permanent neuro-
logical dysfunction or worsening of cognitive and motor
abilities2,3,5,27. The meta-analysis by Marasco et al. also
compared on- and off-pump surgical technique from the
perspective of neurocognitive outcome28. This 2008 study
comprised eight prospective randomized studies with a
total of 892 patients28. Results of this comprehensive
analysis have shown that there is no convincing differ-
ence in the neurocognitive outcome between off- and
on-pump groups28,29. Thus the authors conclude that, for
the neurocognitive function, there is no significant ad-
vantage of off-pump in comparison to the on-pump car-
diac surgical technique28. Results of our study, together
with literature data coming from a variety of randomized
and non-randomized studies that explored this problem,
have shown that there is as yet no definitive recommen-
dation concerning the relative value of on-pump vs. off-
-pump procedure. Although in the last several years
much data have been collected about neuropsychological
dysfunction following coronary artery bypass graft sur-
gery using cardiopulmonary bypass machine, both the
aetiology and mechanism of this phenomenon remain
unclear and probably are multifactorial14,19,21. The rela-
tively old age of patients who undergo CABG and the
widely distributed atherosclerotic disease are probable
reasons for the sequence of vascular events leading to
neurological dysfunction2,6,10,13,27. Regardless of etiologi-
cal factors of postoperative cognitive dysfunction, it seems
that results of most studies indicate current trends. This
is confirmed by the scientific statement of the Council on
Cardiovascular Surgery and Anaesthesia of the Ameri-
can Heart Association, in cooperation with the Quality of
Care and Outcomes Research Interdisciplinary Working
Group2,5,7,12,30. The current trend is that more operations
are performed using off-pump procedure than the stan-
dard CABP yet the length of the hospital stay, mortality
rate, long-term neurological function and cardiac out-
come seem similar for both methods. A thorough preop-
erative preparation of the patient who has a risk of poor
neurocognitive outcome may help clinician choose the
method of revascularization as well as inform the patient
about risks and benefits from the operation in compari-
son with conservative treatments30. Furthermore, moni-
toring cerebral haemodynamics during surgery is ex-
tremely useful as it provides the surgeon with an insight
into the number of cerebral microemboli11,12,21,28. The
surgeon may then decide to switch the surgical technique
or to manipulate instruments and devices in a more care-
ful manner. Yet to provide definitive answers to the ques-
tion if either of the method is truly superior and in which
cases, large prospective randomized studies will be nec-
essary.
Conclusion
The conclusion of our study is that from the perspec-
tive of short-term neurocognitive outcome there is no
significant difference between on-pump and off-pump
surgical techniques. The increase in the serum level of
the neuromarker S100b 48 hours after the surgery may
have prognostic value in patients without clinical signs of
brain damage.
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PREDIKTORI KRATKORO^NOG NEUROKOGNITIVNOG ISHODA NAKON KORONARNE
REVASKULARIZACIJE (CABG) OVISNO O UPOTREBI IZVANTJELESNOG KRVOTOKA
S A @ E T A K
Istra`ivanje je provedeno sa svrhom ispitivanja povezanosti perioperacijske cerebralne mikroembolizacije (HITS) i
poslijeoperacijske dinamike neurobiljega S100b s primjenom izvantjelesnog krvotoka (CPB), te utvr|ivanjem njihovog
u~inka na neurokognitivnu funkciju u ranom poslijeoperacijskom razdoblju. U ispitivanje su uklju~ena 62 konsekutiv-
na mu{ka bolesnika starija od 60 godina predvi|ena za elektivnu operaciju aortokoronarnog premo{tenja. Bolesnici su
regrutirani iz dvije skupine s obzirom na uporabu CPB: on-pump skupina (CPB+, N=30) i off-pump skupina (CPB–,
N=32). Kod svih ispitanika provedeno je intraoperacijsko monitoriranje cerebralne hemodinamike transkranijskim
doplerom u cilju kvantificiranja perioperacijske cerebralne mikroembolizacije. Serumske razine neurobiljega S100b
mjerene su prije operacije, neposredno nakon operacije te 12, 24 i 48 sati od operacije. Neurokognitivni status se ocje-
njivao prije i poslijeoperacijski u tri kognitivne domene. Rezultati istra`ivanja pokazuju da nema zna~ajne razlike iz-
me|u on-pump i off-pump kirur{ke tehnike koronarne revaskularizacije s aspekta kratkoro~nog poslijeoperacijskog
neurokognitivnog ishoda. Perioperacijska cerebralna mikroembolizacija zna~ajno je izra`enija uz primjenu izvan-
tjelesnog krovotoka ali ne utje~e na ranu poslijeoperacijsku neurokognitivnu funkciju, dok porast serumske razine
neurobiljega S100b 48 sati nakon operacije mo`e imati prognosti~ku vrijednost kao mogu}i prediktor poslijeoperacijske
neurokognitivne disfunkcije.
I. Lazibat et al.: Predictors of Neurocognitive Outcome Following CABG, Coll. Antropol. 36 (2012) 3: 827–833
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